Clinical Trial Update: Clinical Trial to to Compare of the Efficacy and Safety of Lipilou® 20 mg and Lipilou® 10 mg [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing the efficacy and safety of Lipilou 20 mg versus Lipilou 10 mg in hypercholesterolemia has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• Lipilou 10 mg
• Lipilou 20 mg

Snippet

Sponsor: Chong Kun Dang Pharmaceutical | Conditions: Hypercholesterolemia | Phase 4 | Status: COMPLETED